Insulin-like growth factor I (IGF-I) is a critical factor in the regulation of various physiologic effects, including bone formation and protein metabolism. Nutrient intake is a main regulator of circulating IGF-I. The relation of zinc status and IGF-I in adulthood has not been studied adequately even though suboptimal intakes of zinc are reported widely in the elderly. This study examined the relation between calculated nutrient intakes from 119 postmenopausal women and concentrations of IGF-I and IGF binding proteins (IGFBPs). Dietary intake was evaluated by 4-d weighed diet records at baseline and 2 y. Mean intakes of 25 nutrients were calculated. Concentrations of IGF-I and IGFBPs were measured by radioimmunoassays at baseline and 2 y. Mean age (63 ± 4 y), weight (66 ± 9 kg), and nutrient intake were correlated with the mean IGF-I concentration at baseline (172 ± 57 g/L) and 2 y (142 ± 43 g/L). IGF-I concentrations were significantly correlated with mean protein and zinc intake at baseline (r = 0.313, P = 0.001; r = 0.298, P = 0.001, respectively) and 2 y (r = 0.256, P = 0.008; r = 0.331, P = 0.001, respectively). After age, weight, and other nutrient intakes were adjusted for in multiple regression at baseline and 2 y, zinc remained the major determinant of IGF-I concentrations. These results suggest that low zinc intake is associated with low IGF-I concentrations in healthy postmenopausal women and that the effects of zinc may be independent of protein intake.
INTRODUCTION
Nutrient intake is an important regulator of insulin-like growth factor I (IGF-I) concentration and IGF-I has been used as a marker of nutritional status (1) . With age, nutrient intake falls (2) because of various factors, including poor dentition, psychologic and physical barriers, illness, and lack of financial resources. The age-related reduction seen in serum IGF-I concentrations (3) and in the aging skeleton (4-6) may be explained in part by this reduction in nutrient intake and may reflect poor nutritional status of the individual. Because IGF-I is a critical factor in the regulation of bone formation, resorption, and calcium homeostasis (4), differences in bone turnover rates seen in the elderly may be associated with individual variations in IGF-I concentrations. Thus, age-related bone loss could in part be associated with reductions in IGF-I concentrations due to reduced nutrient intake.
Restricted intakes of energy, protein, and zinc in animals (7) (8) (9) (10) (11) and children (12, 13) are associated with reduced concentrations of serum IGF-I and reduced growth, both of which are improved with nutritional repletion and in cases of zinc deficiency, zinc supplementation (12, 13) . Recent investigation suggests that the effects of zinc deprivation on IGF-I concentrations may be independent of protein and energy intake (9, 10, 14) . Reductions in energy and zinc intakes lead to reduced concentrations of serum IGF-I, growth hormone receptors, and growth hormone binding proteins (8, 11, 14) . The mechanism responsible for reduced serum IGF-I in zinc deficiency is associated with decreased hepatic IGF-I gene expression and defects in the intracellular growth hormone-signaling pathway that are restored by supplemental zinc (8, 9, 14) . Zinc deficiency per se affects the stability of the 7.5-kilobase IGF-I mRNA transcript and may affect the abundance, binding affinity, and stability of the protein (8, 15) . The majority of circulating IGF-I (75-80%) is bound to the most abundant serum IGF binding protein, IGFBP-3. In states of protein deficiency, the preferential binding of IGF-I to the 150-kD circulating complex composed of IGFBP-3 and an acid-labile subunit is reduced and IGF-I subsequently binds to smaller-molecular-weight IGFBPs. These smaller proteins can pass through capillaries, leading to reduced circulating concentrations of IGF-I (15). This suggests that protein and zinc deficiency may also play a role in the stability of the IGFBPs and the clearance of IGF-I from the serum.
Effects of zinc and other nutritional factors on insulin-like growth factor I and insulin-like growth factor binding proteins in postmenopausal women
The relation of zinc status and serum IGF-I in adulthood has not been adequately studied even though suboptimal intakes of zinc are reported widely in this study and studies of other elderly populations (2, (16) (17) (18) . Poor wound healing, dermatitis, and depressed immune response are commonly seen in aging individuals and are associated with reduced zinc status (19) . Studies in osteoporotic women have shown increased urinary excretion of zinc compared with age-matched control subjects (20) . Hyperzincuria may reflect the increased bone resorption that is associated with aging. Further evidence suggests that bone zinc is lost in times of calcium deficiency (21) , which is pronounced in aging women as calcium requirements increase beyond usual dietary intakes. It seems likely that the increased rates of bone turnover seen in postmenopausal women along with reduced nutrient intake will negatively affect zinc intake and excretion. Concentrations of serum IGF-I may therefore be affected.
The aim of this study was to determine whether nutrient intakes assessed from 4-d weighed diet records were associated with concentrations of IGF-I and serum IGFBPs in a group of healthy community-dwelling postmenopausal women. We measured three IGFBPs in this study. IGFBP-3 was measured because it is the predominant IGFBP in serum. IGFBP-4 and IGFBP-5 were measured because of recent in vitro and in vivo studies that emphasize an important role for these two binding proteins in modulating IGF actions in bone (22) (23) (24) .
SUBJECTS AND METHODS

Subjects
The dietary intake and biochemical data of 129 female subjects entered into a clinical trial to assess the effects of calcium and exercise on bone density (25) were evaluated. One hundred twenty-nine subjects had IGF-I, IGFBP-4, and IGFBP-5 concentrations measured at baseline and 2 y. Only 47 samples were available for analysis of IGFBP-3. Each subject's weight (kg) and stature (cm) was measured.
The four interventions that were studied for 2 y were as follows: placebo; a calcium lactate gluconate tablet (1 g/night, Sandocal; Sandoz, Basel, Switzerland); milk powder containing 1 g Ca; and a calcium tablet (1 g/night) and exercise (25) . Women were eligible for the study if they were between 50 and 70 y of age and were ≥ 10 y postmenopausal. All respondents were white. Subjects were excluded if they had significant chronic diseases or if they had received estrogen, other steroid hormones, anticonvulsant drugs, or thiazide diuretic drugs. They were also excluded if they had taken > 500 mg Ca/d as a supplement for > 1 mo in the past year or if they had exercised for ≥ 2 h/wk in the past year. The Human Rights Committee of the University of Western Australia approved the study. Informed consent was obtained from each subject.
Weighed diet records
Subjects were given comprehensive written and verbal instructions that explained how to complete a 4-d weighed diet record. Subjects were asked to record all foods and beverages consumed for 4 consecutive days, which were randomly assigned-either Sunday through Wednesday or Tuesday through Friday. The same recording days for each subject were maintained throughout the study. Subjects were asked to record brand names when possible, methods of food preparation, and recipes for any mixed dishes eaten during the study period. If they consumed foods and beverages away from home they were asked to use the metric cups, spoons, and grids provided or describe the foods and beverages consumed with household measures if they were unable to use the scales. At the completion of the 4-d weighed diet record, records were checked for discrepancies and omissions by a trained nutritionist or assistant. All data were analyzed by using DIET 1 nutrient calculation software (Xyris Software, Queensland, Brisbane, Australia), which uses the NUTTAB 90 database, a nutritional database of Australian foods (26) . All diet records were analyzed by the same nutritionist. Values for dairy products were adjusted for calcium contents specific for Western Australia (Dairy Industry Authority, Perth, Western Australia). Values for the dietary analyses of vegetarian products were provided by the manufacturer (Sanitarium, Australia) and added to the database. Values for the dietary analyses of four Chinese meals derived from published nutrient-composition data (27) were added to the database.
The age-specific basal metabolic rate (BMR) for each subject was calculated from each subject's body weight by using the Schofield equation (28) . The ratio of the average energy intake to BMR (EI:BMR) was calculated for each subject. To reduce the effect of underestimating the intake of energy and other nutrients, biased records, ie, those with EI:BMR below the limit (0.88) compatible with long-term weight maintenance defined by Goldberg et al (29) for an individual for a 4-d record, were identified and excluded from the analyses. Of the 129 subjects, 126 subjects completed a diet record at 2 y. Nine at baseline and 19 subjects at 2 y had an EI:BMR < 0.88 and these data were rejected. One subject had energy intake 3 SDs above the mean energy intake at both time points and these data were rejected. At baseline and 2 y, 119 and 106 subjects were included in the respective analyses.
Biochemical and anthropometric measurements
A blood sample was collected from each subject after they had fasted overnight. These samples were not taken during the dietary recording period. IGF-I was measured by a competitivebinding double-antibody radioimmunassay using a kit from Nichols Corning (San Juan Capistrano, CA) after acid ethanol cryoprecipitation and extraction. Eight IGF-I runs were undertaken and eight separate assay kits were used. Paired samples from the same subject (baseline and 2 y) were run with the same kit. The intraassay CVs were 6.11%, 5.17%, 1.79%, 3.28%, 0.68%, 3.89%, 1.85%, and 4.99%. The interassay CV for the set was 5.02%. IGFBP-3 was measured by using a two-site immunoradiometric kit (Diagnostic Systems Laboratories, Webster, TX). Three Diagnostic System Laboratories immunoradiometric kits were used for the IGFBP-3 analyses. The intraassay CVs were 0.53%, 1.41%, and 3.61% and the interassay CV was 1.02%. IGFBP-4 and IGFBP-5 concentrations were measured by radioimmunoassays (23, 24) . These assays showed no significant cross-reactivity with any of the other known IGFBPs. Inter-and intraassay CVs were < 10% for both assays.
Statistical analyses
Descriptive statistics include means and SDs for the biochemical measurements and dietary intake averaged over 4 d. The percentage of subjects who achieved the recommended dietary intake (RDI) or ≥ 70% of the RDI for women aged ≥ 54 y (28) NUTRIENT INTAKE AND IGF-I AND IGF BINDING PROTEINSwas calculated for protein and zinc. At baseline and 2 y, interrelations between dietary intakes and serum IGF-I and IGFBPs were calculated by using Spearman's correlation coefficient. Multiple regression analysis was used to determine the significant determinants of serum IGF-I concentration at each time point. Paired sample t test was used to examine differences in nutrient intake and serum IGF-I and IGFBPs between baseline and 2 y. One-way analysis of variance (ANOVA) with Duncan's new multiple-range test was used to determine the difference between treatment groups (placebo, calcium, calcium and exercise, and milk) in the change in zinc intake and change in IGF-I and IGFBPs during the study. Duncan's test was only used if the one-way ANOVA was significant. All P values were two tailed at a significance level < 0.05. The statistical package used was SPSSPC for Windows (SPSS, Inc, Chicago).
RESULTS
At baseline and 2 y, 119 and 106 subjects were included in respective analyses except for that of IGFBP-3. The mean (± SD) age at baseline was 62.9 ± 4.4 y. The subjects were on average 15.5 ± 4.8 y past menopause with an average body weight of 66 ± 9.4 kg and height of 161 ± 6.0 cm.
Nutrient intake
Baseline and 2-y mean intakes of all nutrients are listed in Table 1 . Intakes of calcium, sodium, and phosphorus increased significantly between baseline and 2 y ( Table 1) . Intakes of energy, fat, cholesterol, saturated fat, iron, and fiber decreased significantly between baseline and 2 y (Table 1) . At baseline and 2 y, 23% and 31% of subjects, respectively, had zinc intakes < 8.4 mg/d. Most subjects (86% and 88%) had intakes below the RDI for zinc of 12 mg at baseline and 2 y, respectively. Ninetyeight percent and 100% of subjects had protein intakes greater than the RDI for protein (45 g) at baseline and 2 y, respectively.
IGF-I and nutrient intake
At baseline, positive correlations were found between IGF-I and the mean dietary intakes of several nutrients: calcium, cholesterol, energy, iron, potassium, magnesium, sodium, niacin, phosphorus, protein, riboflavin, thiamine, and zinc ( Table 2) . The significant positive correlation between dietary zinc intake and IGF-I concentration (Figure 1) was not influenced by the 2 Intakes include the nutrient content of the intervention supplement. 3 x -± SD; range in parentheses. 4 Significantly different from baseline, P < 0.05 (paired sample t test). 5 n = 43 at baseline; n = 39 at 2 y.
subject with an IGF-I concentration of 399 g/L. Thus, the data point was included in the analyses. Multiple regression was performed with IGF-I concentration as the dependent variable and all nutrient intakes correlated with IGF-I in univariate analysis, age, and weight as the independent variables. The results of this analysis showed that zinc and age were the only significant determinants of IGF-I concentration ( Table 3) . At 2 y, IGF-I was positively correlated only with dietary intakes of zinc (Figure 2 ) and protein ( Table 2 ). Multiple regression was performed with IGF-I concentration measured at 2 y as the dependent variable and all mean nutrient intakes correlated with IGF-I in univariate analysis at baseline, age, weight, and treatment group as the independent variables. The results of this analysis showed that zinc was the only significant determinant of IGF-I concentration at 2 y (Table 3) .
Paired samples of baseline and 2-y concentrations of IGF-I (r = 0.710, P < 0.001), IGFBP-3 (r = 0.717, P < 0.001), IGFBP-4 (r = 0.235, P < 0.015), and IGFBP-5 (r = 0.430, P < 0.001) were significantly positively correlated. For the whole group, IGF-I (P < 0.001) and IGFBP-3 (P < 0.03) concentrations fell over the 2 y of the study, whereas IGFBP-4 concentrations rose significantly (P < 0.001) ( Table 1) .
At baseline, dietary intakes of energy (r = 0.585, P < 0.001), protein (r = 0.354, P < 0.001), and zinc (r = 0.288, P = 0.003) were significantly correlated with their counterparts at 2 y. Zinc and protein intakes were highly correlated at baseline (r = 0.793, P < 0.001) and 2 y (r = 0.885, P < 0.001), more so than energy and protein intakes at baseline (r = 0.532, P < 0.001) and 2 y (r = 0.567, P < 0.001). During the 2 y, the change in zinc intake was significantly greater in the milk-supplemented group (1.27 ± 2.11 mg/d) than in the calcium and exercise (Ϫ0.63 ± 2.43 mg/d), placebo (Ϫ1.68 ± 2.87 mg/d), or calciumsupplemented groups (Ϫ0.96 ± 2.14 mg/d). However, the change in concentrations of IGF-I and the binding proteins was not significantly different between the treatment groups.
Relation between IGF-I, IGFBPs, age, and nutrient intake
The baseline and 2-y concentrations of IGF-I and the IGFBPs are reported in Table 1 . At baseline, age was negatively correlated with concentrations of IGF-I (r = Ϫ0.269, P < 0.01) and IGFBP-3 (r = Ϫ0.369, P < 0.01) and positively correlated with concentrations of IGFBP-4 (r = 0.219, P < 0.05). At 2 y, age was negatively correlated with only IGFBP-3 (r = Ϫ0.432, P < 0.01).
At baseline, IGF-I was significantly correlated with IGFBP-3 (r = 0.627, P < 0.001) and IGFBP-5 (r = 0.459, P < 0.001). IGFBP-3 was correlated with IGFBP-5 (r = 0.499, P = 0.001). At 2 y, IGF-I was significantly correlated with IGFBP-3 (r = 0.424, P = 0.007) and negatively correlated with IGFBP-4 (r = 20.201, P = 0.039). IGFBP-4 was correlated with IGFBP-5 (r = 0.328, P = 0.001).
At baseline, IGFBP-3 was correlated with mean riboflavin intake (r = 0.392, P = 0.009), IGFBP-4 was negatively correlated with mean phosphorus intake (r = Ϫ0.273, P = 0.003), and IGFBP-5 was positively correlated with mean sodium (r = 0.194, P = 0.035) and phosphorus (r = 0.205, P = 0.026) intakes. At 2 y, IGFBP-3 was not correlated with the mean intake of any nutrients. IGFBP-4 was correlated with mean fat intake (r=0.210, P = 0.031) and mean saturated fat intake (r = 0.248, P = 0.010). IGFBP-5 was negatively correlated with mean vitamin C intake (r = Ϫ0.291, P = 0.002). At baseline and 2 y the IGFBPs were not consistently correlated with mean intakes of nutrients in univariate analysis and were not analyzed further by using multiple regression analyses.
DISCUSSION
These results indicate that zinc intake measured by a 4-d weighed diet record was correlated with serum IGF-I concentrations better than was protein intake or age in a group of healthy, community-dwelling postmenopausal women. Previous investigations support the association between zinc intake and IGF-I concentrations in states of malnutrition in animal models (7-9, 11, 14) and children (12, 13) . Zinc deficiency reduces IGF-I concentrations and, thus, growth is compromised. With zinc supplementation, concentrations of IGF-I and growth are improved (9, 12, 13) . Evidence suggests that decreased hepatic IGF-I gene expression and defects in the intracellular growth hormone-signaling pathway (8, 9, 14) occur in the zinc-deficient state, which NUTRIENT INTAKE AND IGF-I AND IGF BINDING PROTEINS 203 
TABLE 2
Correlation coefficients of nutrient intake and serum insulin-like growth factor I (IGF-I) measured at baseline and 2 y Baseline IGF-I 2-y IGF-I lead to a reduction in the production of IGF-I. Even though the subjects in this study were healthy, community-dwelling individuals who ate self-selected diets, during the study one-quarter of subjects had a zinc intake < 70% of the RDI (< 8.4 mg) and ≥ 86% of the subjects had zinc intakes below the RDI (12 mg).
Mean energy intakes during the study were slightly below the recommended range for older women weighing 65 kg (7300-8400 kJ/d) (28) . These intakes, however, were sufficient to be considered above the limit compatible with long-term weight maintenance defined by Goldberg et al (29) . This suggests that even in women with adequate intakes of energy and protein, zinc intake influences IGF-I concentrations.
Restriction of dietary protein in animals suggests that a postreceptor defect is responsible for a reduction in IGF-I mRNA transcription leading to a reduction in IGF-I production (15) . Further, the binding affinity of IGF-I to its preferential binding protein IGFBP-3 is altered in the protein-deficient state and clearance from serum is affected. In this study, protein intake was above recommendations (45 g/d; 28) made for Westernized diets (2, 18) , which may explain the lack of significant relations between protein intake and IGFBP-3. These relations may have been altered if the subjects were fasting or protein deficient. Alternatively, in this study the small sample size at baseline (n = 43) and 2 y (n = 39) for IGFBP-3 may in part have accounted for the lack of significance.
The major source of zinc consumed by most individuals is animal products (51%), namely, meat and meat products (2) . Cereals and milk products contribute lesser amounts, 17% and 12%, respectively (2) . Previous investigation focused on the effects of macronutrients such as energy and protein on IGF-I action. After fasting, the amount of energy and quality of protein are important in the recovery of serum IGF-I concentrations (1). Moreover, protein deprivation alters the biological action and expression of IGF-I, its clearance, binding, and degradation and may increase organ-specific resistance to its growth-mediating actions. Because zinc is provided by protein foods, especially animal products, the role of zinc per se in different states of malnutrition and accompanying effects on IGF-I action has been difficult to distinguish. Zinc plays a role in the nutritional regulation of IGF-I and may have been a surrogate for the action of protein in previous investigations (1, 11) . This study supports evidence that the effects of zinc intake on IGF-I concentrations may be independent of protein intake, despite the cocorrelation between zinc and protein intakes during the study.
IGF-I is a critical factor in the regulation of bone turnover (4, 30, 31) . Changes in serum concentrations of IGF-I may occur because of inadequate dietary sources of nutrients such as zinc, which are common (2, 16, 18) . Moreover, skeletal IGF-I concentrations are positively correlated with serum IGF-I and negatively correlated with age (3, 5) , as supported by this study. These factors suggest that age-related bone loss may be associated with reductions in local and systemic concentrations of IGF-I associated with reduced nutrient intake. Evidence of hyperzincuria in osteoporotic patients was reported (20) . Taken together with inadequate zinc intake and increased bone resorption, postmenopausal women are at increased risk of reducing their zinc status. Paradoxically, the zinc released by bone resorption may actually tend to protect elderly women from a reduced zinc intake. These findings warrant further investigation into the relation of zinc intake, IGF-I, and bone health.
The nutritional regulation of IGFBPs in fasting and chronic dietary restriction has been reviewed extensively (15, 32) . Differences in abundance of the binding proteins occur in dietary restriction. Organ specificity is also important in their regulation. Reductions in IGFBP-3 have been noted in dietary restriction and plasma IGF-I clearance is increased in conditions in which IGFBP-3 is reduced. During the study, those subjects consuming a daily milk supplement had a significant rise in zinc intake that was not paralleled by an increase in IGF-I or IGFBP-3. Correlations with IGFBP-4 and IGFBP-5 were not 204 DEVINE ET AL A shortcoming of this study was the lack of measurement of IGFBP-1, which is regulated by protein and calcium intake, and which may regulate IGF-I bioactivity. Serum zinc concentrations were not measured either and would have provided more presumptive evidence that zinc and IGF-I are linked. The effect of IGF-I and zinc intake may be underestimated in this population because of the healthy nature of the subjects. If the population were extended to include frail elderly, in whom nutrient intake may be even lower, a wider range of serum IGF-I values would be expected and a more positive effect (r value) would be seen across a range of nutrient intakes and expressions of serum IGF-I.
The effect of calcium supplementation from a food source or tablet was studied in this population and described in detail elsewhere (33) . Significant changes in nutrient intake were reflected in dietary intake data and were related to the type of intervention. Significant correlations between baseline and 2-y intakes of energy, protein, and zinc suggest that individuals consume similar diets over time even when taking part in a calcium intervention trial. Recently, Wood and Zheng (34) reported a detrimental effect of concurrent calcium supplementation on zinc absorption that may be offset by zinc being included in the calcium supplement. If high-calcium diets reduce zinc absorption and balance, it may therefore be necessary to further increase the requirements for zinc in elderly postmenopausal women. However, in this study the calcium supplement was not administered with food.
In conclusion, this study extends the associations between zinc intake and serum IGF-I concentration seen in the nutrientrestricted animal models and children to healthy postmenopausal women. Furthermore, intakes of certain nutrients, primarily zinc and protein, assessed by a weighed diet record correlated with IGF-I concentrations at two different time points. After age, weight, and other nutrient intakes were adjusted for, zinc intake remained the major determinant of IGF-I concentration. This study provides additional evidence from 4-d weighed diet record data of the association between zinc intake and IGF-I concentrations. Even though dietary records are associated with user and interpreter errors (35) , they have proved to be a tool able to elicit a relation previously seen in studies of malnourished animals and children. These findings warrant further investigation into the relation of zinc intake with IGF-I and health in an aging population.
